AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)
$14.59 0.68 (4.8886%)
Analysed AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) News Sources
Amylyx (AMLX) Q1 2026 Earnings Transcript
08-05-2026
fool.com
Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus
14-05-2026
marketbeat.com
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation
15-05-2026
yahoo.com
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
19-05-2026
fool.com
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares
19-05-2026
fool.com
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 2026 Results and Pipeline Progress
20-05-2026
yahoo.com
Amylyx Stock: Why the Full Pipeline Story Matters
24-05-2026
marketbeat.com
A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Its Recent Share Price Rebound
01-06-2026
yahoo.com
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026
08-06-2026
yahoo.com
Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape
10-06-2026
marketbeat.com
What is the current price of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)?
The current price of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) is $14.59.
AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) since the previous trading day is $0.68.
AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) since the previous trading day is 4.8886%.
What is the most recent average sentiment score for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)?
The most recent average sentiment score for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)?
The most recent sentiment for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) is .
SEC-8K** Filing Available For AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.